7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-3-CARBOXAMIDO-6-ETHOXYCARBONYLPYRAZOLO-[1,5-A]-PYRIMIDINE
Compound with spectra: 1 NMR
![7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-3-CARBOXAMIDO-6-ETHOXYCARBONYLPYRAZOLO-[1,5-A]-PYRIMIDINE](/api/compound/20jMVpz2I3p.png?ph=true&h=300&w=458 "7-[4-(N-ACETYL-N-ETHYL)-AMINOPHENYL]-3-CARBOXAMIDO-6-ETHOXYCARBONYLPYRAZOLO-[1,5-A]-PYRIMIDINE")
| SpectraBase Compound ID | 20jMVpz2I3p |
|---|---|
| InChI | InChI=1S/C20H21N5O4/c1-4-24(12(3)26)14-8-6-13(7-9-14)17-15(20(28)29-5-2)10-22-19-16(18(21)27)11-23-25(17)19/h6-11H,4-5H2,1-3H3,(H2,21,27) |
| InChIKey | ZHVJBIBUTBJHHT-UHFFFAOYSA-N |
| Mol Weight | 395.42 g/mol |
| Molecular Formula | C20H21N5O4 |
| Exact Mass | 395.159354 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Ethyl 5-chloro-7-(3-methoxyphenyl)pyrazolo[1,5-a]pyrimidine-6-carboxylate
9-[(N-ACETYL-N-ETHYL)-AMINO]-6,7-DIHYDROBENZO-[H]-PYRAZOLO-[1,5-A]-QUINAZOLINE
2-Anilino-N-(4-methylphenyl)-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
N-(4-Chlorophenyl)-2-[(4-chlorophenyl)amino]-7-phenylpyrazolo-[1,5-a]pyrimidine-3-carboxamide
N-(1-adamantylmethyl)-5-(3,4-dimethoxyphenyl)-7-(trifluoromethyl)-3-pyrazolo[1,5-a]pyrimidinecarboxamide
Ethyl 2-hydroxyl-5,7-diphenylpyrazolo[1,5-a]pyridine-3-carboxylate
2-Anilino-N-(4-methoxyphenyl)-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
2-Anilino-N-(4-bromophenyl)-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
2-Anilino-N,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
2-(benzylamino)-6-[(1R,2S)-1,2-dibenzoxy-3-hydroxy-propyl]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid ethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of pyrazolo[1,5-a]-, 1,2,4-triazolo[1,5-a]- and imidazo[1,2-a]pyrimidines related to zaleplon, a new drug for the treatment of insomnia | Journal of Heterocyclic Chemistry | 2001 |